Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Standish-Barry, H. M. A. S.
Bouras, N.
Bridges, P. K.
and
Watson, J. P.
1983.
A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder.
Psychopharmacology,
Vol. 81,
Issue. 3,
p.
258.
Bollini, P.
Cotecchia, S.
De Blasi, A.
S., Romandini
and
G., Tognoni
1984.
Drugs: Guide and caveats to explanatory and descriptive approaches—II. Drugs in psychiatric research.
Journal of Psychiatric Research,
Vol. 18,
Issue. 4,
p.
391.
Mikuni, Masahiko
and
Meltzer, Herbert Y.
1984.
Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof.
Life Sciences,
Vol. 34,
Issue. 1,
p.
87.
Goodwin, G.M.
and
Metz, A.
1985.
Preclinical Psychopharmacology.
p.
206.
Zetin, Mark
Warren, Stacey
Pangan, Editha A.
and
Stasiek, Chris
1986.
Refractory depression.
Stress Medicine,
Vol. 2,
Issue. 2,
p.
153.
Maragakis, B. P.
1990.
A double-blind comparison of oral amitriptyline and low-dose intramuscular flupenthixol decanoate in depressive illness.
Current Medical Research and Opinion,
Vol. 12,
Issue. 1,
p.
51.
Gruber, Amanda J.
and
Cole, Jonathan O.
1991.
Antidepressant Effects of Flupenthixol.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 11,
Issue. 6,
p.
450.
Budde, Gisela
1992.
Efficacy and tolerability of flupenthixol decanoate in the treatment of depression and psychosomatic disorders: A multicenter trial in general practice.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 16,
Issue. 5,
p.
677.
Laux, G.
Delini-Stula, A.
Breyer-Pfaff, U.
Rickels, K.
Osterheider, M.
Sieberns, S.
Heininger, K.
Becker, T.
Dietmaier, O.
and
Wendt, G.
1993.
Neuro-Psychopharmaka.
p.
355.
Okada, Fumihiko
1995.
Why Can Low Doses of Sulpiride Counteract Depression?.
Journal of Clinical Psychopharmacology,
Vol. 15,
Issue. 6,
p.
442.
Bandelow, B.
1998.
Flupentixol — Typisches oder atypisches Wirkspektrum?.
p.
67.
Levin, Frances Rudnick
Evans, Suzette M.
Coomaraswammy, Siobhan
Collins, Eric D.
Regent, Nicole
and
Kleber, Herbert D.
1998.
Flupenthixol Treatment for Cocaine Abusers with Schizophrenia: A Pilot Study.
The American Journal of Drug and Alcohol Abuse,
Vol. 24,
Issue. 3,
p.
343.
Soyka, M.
and
Seemann, O.
1998.
Flupentixol — Typisches oder atypisches Wirkspektrum?.
p.
79.
Verbeeck, W.J.C.
Berk, M.
Paiker, J.
and
Jersky, B.
2001.
The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression.
European Neuropsychopharmacology,
Vol. 11,
Issue. 3,
p.
215.
Laux, Gerd
2021.
NeuroPsychopharmacotherapy.
p.
1.
P., SUGANDHA KUMAR
and
RAMBABU, KANTIPUDI
2022.
SIMULTANEOUS DETERMINATION OF FLUPENTIXOL AND NORTRIPTYLINE HCl USING RP-HPLC WITH PDA DETECTOR.
International Journal of Applied Pharmaceutics,
p.
167.
Laux, Gerd
2022.
NeuroPsychopharmacotherapy.
p.
1753.
eLetters
No eLetters have been published for this article.